Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of Tuesday, October 6, 2026.
OPERATING MARGIN
N/A
Electra Therapeutics Inc.
Market Cap
$206.61M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$202.05M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$218.42M
Operating Margin
40.94%
TTM Avg
-5.20%
3Y Avg
-130.22%
5Y Avg
-446.71%
Market Cap
$192.97M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$220.94M
Operating Margin
-692.83%
TTM Avg
-418.51%
3Y Avg
-274.13%
5Y Avg
-339.94%
Market Cap
$184.12M
Operating Margin
-13.21%
TTM Avg
-18.79%
3Y Avg
-19.38%
5Y Avg
-19.19%
Market Cap
$179.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$176.96M
Operating Margin
-96.56%
TTM Avg
-271.71%
3Y Avg
-1442.10%
5Y Avg
-1248.16%
Market Cap
$236.56M
Operating Margin
-31.37%
TTM Avg
-39.87%
3Y Avg
-74.09%
5Y Avg
-70.30%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Electra Therapeutics Inc. (ETRA) | $206.61M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Compugen Ltd. (CGEN)vs › | $218.42M | 40.94% | -5.20% | -130.22% | -446.71% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alector, Inc. (ALEC)vs › | $220.94M | -692.83% | -418.51% | -274.13% | -339.94% |
| Journey Medical Corporation (DERM)vs › | $184.12M | -13.21% | -18.79% | -19.38% | -19.19% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | -96.56% | -271.71% | -1442.10% | -1248.16% |
| Biodesix, Inc. (BDSX)vs › | $236.56M | -31.37% | -39.87% | -74.09% | -70.30% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | -152.19% | -95.13% | -132.07% | -169.10% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
